Literature DB >> 13495346

The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin.

H STORMORKEN.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION

Mesh:

Substances:

Year:  1957        PMID: 13495346     DOI: 10.3109/00365515709079970

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  9 in total

1.  Disseminated intravascular coagulation and head injury.

Authors:  C J Vecht; C T Sibinga; J M Minderhoud
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

2.  The thrombotic activity of activation product.

Authors:  E S HENDERSON; S L RAPAPORT
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

3.  Haemostatic defects in polycythaemia vera.

Authors:  N E Stathakis; A G Papayannis; G Arapakis; C Gardikas
Journal:  Blut       Date:  1974-08

4.  Intravascular coagulation secondary to cavernous hemangioma in infancy: response to radiotherapy.

Authors:  A Pyesmany; H Ekert; K Williams; R Hittle
Journal:  Can Med Assoc J       Date:  1969-06-14       Impact factor: 8.262

5.  Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.

Authors:  N E Stathakis; T C Economopoulos; A G Papayannis; D Thomopoulos
Journal:  Blut       Date:  1977-03

6.  Factor V anticoagulants: clinical, biochemical, and immunological observations.

Authors:  D I Feinstein; S I Rapaport; W G McGehee; M J Patch
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

7.  Metabolism of fibrinogen in cirrhosis of the liver.

Authors:  G N Tytgat; D Collen; M Verstraete
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

8.  Haemostatic defect in non-immune patients with falciparum malaria: no evidence of diffuse intravascular coagulation.

Authors:  J Vreeken; T M Cremer-Goote
Journal:  Br Med J       Date:  1978-08-19

9.  A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6.

Authors:  T S Zimmerman; C M Arroyove; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.